Kronos Bio, Inc. (KRON)
0.8800
0.00 (0.00%)
Inactive · Last trade price on Jun 20, 2025
Kronos Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -64.49 | -86.08 | -112.67 | -133.2 | -151.08 | -88.44 |
Depreciation & Amortization | 1.46 | 1.72 | 2.14 | 2.27 | 1.98 | 0.84 |
Other Amortization | - | - | - | - | - | 3.89 |
Asset Writedown & Restructuring Costs | 19.54 | 27.63 | 3.16 | - | - | 3.57 |
Loss (Gain) From Sale of Investments | -1.86 | -2.81 | -5.34 | -0.53 | 4 | 0.33 |
Stock-Based Compensation | 6.03 | 9.22 | 24.98 | 31.15 | 26.21 | 3.75 |
Other Operating Activities | 2.15 | 2.78 | 3.27 | 3.22 | 2.59 | 31.7 |
Change in Accounts Payable | -0.66 | 1.52 | -4.15 | 4.03 | -3.2 | 2.81 |
Change in Unearned Revenue | -11.19 | -11.85 | 13.71 | - | - | - |
Change in Other Net Operating Assets | -5.36 | -7.57 | -3.69 | 2.15 | 1.58 | 3.65 |
Operating Cash Flow | -54.38 | -65.44 | -78.58 | -90.93 | -117.92 | -37.91 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Capital Expenditures | 0 | -0 | -0.68 | -0.58 | -4.26 | -9.57 |
Investment in Securities | 99.51 | 85.44 | 67.05 | -31.65 | 67.98 | -150.67 |
Investing Cash Flow | 99.51 | 85.44 | 66.37 | -32.22 | 63.72 | -160.24 |
Financing Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Long-Term Debt Issued | - | - | - | - | - | 151.28 |
Long-Term Debt Repaid | - | - | - | - | -0.01 | -0.03 |
Net Debt Issued (Repaid) | - | - | - | - | -0.01 | 151.24 |
Issuance of Common Stock | 0.25 | 0.25 | 0.57 | 0.85 | 4.47 | 264.37 |
Financing Cash Flow | 0.25 | 0.25 | 0.57 | 0.85 | 4.46 | 415.61 |
Net Cash Flow
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Cash Flow | 45.38 | 20.25 | -11.65 | -122.3 | -49.74 | 217.47 |
Free Cash Flow
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Free Cash Flow | -54.38 | -65.44 | -79.26 | -91.5 | -122.18 | -47.48 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -591.55% | -664.49% | -1260.51% | - | - | - |
Free Cash Flow Per Share | -0.90 | -1.09 | -1.37 | -1.63 | -2.23 | -2.92 |
Levered Free Cash Flow | -30.66 | -30.74 | -43.82 | -43.3 | -72.4 | -35.88 |
Unlevered Free Cash Flow | -30.66 | -30.74 | -43.82 | -43.3 | -72.4 | -37.34 |